L-Asparaginase for newly diagnosed extra-nodal NK/T-cell lymphoma: systematic review and meta-analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
L-Asparaginase for newly diagnosed extra-nodal NK/T-cell lymphoma: systematic review and meta-analysis
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 17, Issue 8, Pages 759-768
Publisher
Informa UK Limited
Online
2017-06-16
DOI
10.1080/14737140.2017.1344100
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan
- (2017) Motoko Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Extra-nodal natural killer/T cell lymphoma in elderly patients: the impact of aging on clinical outcomes and treatment tolerability
- (2016) Sung Min Kim et al. ANNALS OF HEMATOLOGY
- Comparative immunogenicity and structural analysis of epitopes of different bacterial L-asparaginases
- (2016) Vadim S. Pokrovsky et al. BMC CANCER
- A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China
- (2016) Rong Liang et al. HEMATOLOGICAL ONCOLOGY
- Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer/T-cell lymphoma
- (2016) Wen Wei et al. Hematology
- Retrospective Study of Pegaspargase, Gemicitabine, Oxaliplatin and Dexamethasone (Peg-GemOD) as a First-Line Therapy for Advanced-Stage Extranodal NK/T Cell Lymphoma
- (2016) Yi-yun Yao et al. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
- NK/T Cell Lymphoma: A Tertiary Centre Experience
- (2016) Neeraj Arora et al. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
- Sequential DICE combined withl-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma
- (2016) Li-Hua Dong et al. LEUKEMIA & LYMPHOMA
- Encouraging experience in the treatment of nasal type extra-nodal NK/T-cell lymphoma in a non-Asian population
- (2016) Shunan Qi et al. LEUKEMIA & LYMPHOMA
- The Modified Heparin-Binding l-Asparaginase of Wolinella succinogenes
- (2016) E. P. Sannikova et al. MOLECULAR BIOTECHNOLOGY
- Retrospective Study of Pegaspargase, Gemicitabine, Oxaliplatin and Dexamethasone (Peg-GemOD) as a First-Line Therapy for Advanced-Stage Extranodal NK/T Cell Lymphoma
- (2016) Yi-yun Yao et al. Indian Journal of Hematology and Blood Transfusion
- NK/T Cell Lymphoma: A Tertiary Centre Experience
- (2016) Neeraj Arora et al. Indian Journal of Hematology and Blood Transfusion
- Treatment outcome of patients with advanced stage natural killer/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy
- (2015) Xi-Wen Bi et al. ANNALS OF HEMATOLOGY
- Radiotherapy and PGEMOX/GELOX regimen improved prognosis in elderly patients with early-stage extranodal NK/T-cell lymphoma
- (2015) Xi-wen Bi et al. ANNALS OF HEMATOLOGY
- Trial of LVDP regimen (l-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphoma
- (2015) Y. Q. Wang et al. MEDICAL ONCOLOGY
- Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus l-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL)
- (2014) Miso Kim et al. ANNALS OF HEMATOLOGY
- New prognostic model for extranodal natural killer/T cell lymphoma, nasal type
- (2014) Qingqing Cai et al. ANNALS OF HEMATOLOGY
- Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patients
- (2014) Seok Jin Kim et al. ANNALS OF HEMATOLOGY
- Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with l-asparaginase-containing chemotherapy—a single institution experience
- (2014) Jian Zang et al. ANNALS OF HEMATOLOGY
- Concurrent chemoradiotherapy followed by l-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study
- (2014) Seok Jin Kim et al. ANNALS OF HEMATOLOGY
- A single institution experience of extranodal natural killer/T cell lymphoma of nasal type
- (2014) Luluel Khan et al. LEUKEMIA & LYMPHOMA
- Combination of gemcitabine, l-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term follow-up
- (2014) Wang Liang et al. MEDICAL ONCOLOGY
- A Phase II Study of Ifosfamide, Methotrexate, Etoposide, and Prednisolone for Previously Untreated Stage I/II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of the Korean Cancer Study Group
- (2014) T. M. Kim et al. ONCOLOGIST
- International analysis of the frequency and outcomes of NK/T-cell lymphomas
- (2013) Basem M. William et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- How I treat NK/T-cell lymphomas
- (2013) E. Tse et al. BLOOD
- A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type
- (2013) Ningjing Lin et al. Journal of Hematology & Oncology
- Low level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphoma
- (2013) Liang Wang et al. TUMOR BIOLOGY
- SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
- (2012) Y.-L. Kwong et al. BLOOD
- Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 trial
- (2012) Seok Jin Kim et al. EUROPEAN JOURNAL OF CANCER
- Phase 2 trial of “Sandwich”L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma
- (2011) Ming Jiang et al. CANCER
- Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
- (2011) Motoko Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of localized extranodal NK/T cell lymphoma, nasal type
- (2010) Seok Jin Kim et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
- (2010) David Moher et al. International Journal of Surgery
- Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211
- (2009) Motoko Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
- (2009) Seok Jin Kim et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started